SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-002077
Filing Date
2020-03-05
Accepted
2020-03-05 17:01:33
Documents
79
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cycc-20191231x10k.htm 10-K 2698289
2 EX-4.7 cycc-20191231ex47c4a9d09.htm EX-4.7 153395
3 EX-23.1 cycc-20191231ex23190be00.htm EX-23.1 3701
4 EX-31.1 cycc-20191231ex3113c71c2.htm EX-31.1 14445
5 EX-31.2 cycc-20191231ex312b15d62.htm EX-31.2 14787
6 EX-32.1 cycc-20191231ex32179f4fb.htm EX-32.1 7474
7 EX-32.2 cycc-20191231ex3227a96df.htm EX-32.2 7546
  Complete submission text file 0001558370-20-002077.txt   8095166

Data Files

Seq Description Document Type Size
8 EX-101.INS cycc-20191231.xml EX-101.INS 1487249
9 EX-101.SCH cycc-20191231.xsd EX-101.SCH 50869
10 EX-101.CAL cycc-20191231_cal.xml EX-101.CAL 56121
11 EX-101.DEF cycc-20191231_def.xml EX-101.DEF 195544
12 EX-101.LAB cycc-20191231_lab.xml EX-101.LAB 425968
13 EX-101.PRE cycc-20191231_pre.xml EX-101.PRE 358713
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 20691544
SIC: 2834 Pharmaceutical Preparations